Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Moxetumomab pasudotox

Cat. No.: IBDI-431990

Moxetumomab pasudotox (CAT 8015) is anti-CD22 immunotoxin containing an anti-CD22 Fv and Pseudomonas exotoxin. CD22 is a cell surface receptor expressed on a variety of malignant B-cells. Moxetumomab pasudotox can be used in the research of hairy cell leukemia (HCL).

Size (Solid):

Product Details

Target Antibody-Drug Conjugates (ADCs) | CD22
Molecular Weight 63.5
Synonyms CAT 8015, HA 22, Anti-Human CD22 Recombinant Antibody
SMILES [Moxetumomab pasudotox]

Storage & Handling

Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.